Navigation Links
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)
Date:7/16/2014

trauma, and other chronic and acute medical conditions.  As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals, and biotechnology to create products that advance patient care worldwide.  By mid-2015, Baxter expects to establish the BioScience businesses as a separate, publicly traded, innovation oriented biotechnology firm.

The exclusive collaboration between Baxter and Coherus includes development and commercialization for the etanercept biosimilar in Europe, Canada, Brazil and certain other markets.

This release includes forward-looking statements by Baxter International Inc. related to a clinical trial being conducted by its partner, Coherus BioSciences. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; clinical results; changes in laws and regulations; product quality or supply or patient safety issues; and other risks identified in Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Coherus BioSciences Contact
Beth Jimison
650-649-3526
BJimison@Coherus.com

Logo - http://photos.prnewswire.com/prnh/20120507/SF01448LOGO


'/>"/>
SOURCE Coherus BioSciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
2. Coherus anuncia que CHS-0214 (biosimilar etanercept propuesto) supera punto final primario en decisivo estudio clínico farmacocinético
3. Coherus Biosciences als Präsentator zur J.P. Morgan Annual Healthcare Conference 2014 eingeladen
4. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015 Boston Scientific Corporation (NYSE: ... and business highlights for the second quarter ended June 30, ... The call will be hosted by Mike ... Brennan , executive vice president and chief financial officer. ... available via the Boston Scientific website. Webcast registration is available ...
(Date:7/1/2015)... (Continental) announced it is expanding its Baltimore -based clinical studies network and ... for unique patient populations.  Photo - ... ... ... "Continental hosts clinical studies for physicians ...
(Date:7/1/2015)... ST. LOUIS , July 1, 2015 ... the first quarter of 2015 compared to the same ... of the Express Scripts (NASDAQ: ESRX ) Exchange ... the first quarter of 2014, the number of new ... medication declined 18 percent in the first quarter of ...
Breaking Medicine Technology:Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5
... MADISON, Wis. and HOPKINTON, Mass., July 12, 2011 ... Caliper Life Sciences, Inc. (NASDAQ: CALP ... development and optimization of automated protocols for the ... Caliper,s Sciclone® NGS Workstation.  The collaboration aims to ...
... 2011 Steven Leinbach, of Elkhart, Indiana, has been ... his outstanding contributions and achievements in the pharmaceutical field. ... Mr. Leinbach has had more than 23 ... currently serving as Senior Quality Engineer with Capsugel, a ...
Cached Medicine Technology:Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 2Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 3Steven Leinbach Recognized By Strathmore's Who's Who Worldwide Publication 2
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – today announced that they will welcome four new members to their industry ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC Corporation today announced ... Spirulina-derived natural blue food coloring. Construction of the plant, which is located on ... base, began in May 2014. After commissioning, commercial production is expected to begin ...
(Date:7/1/2015)... ... 2015 , ... OncLive® will team with ... as it further expands its Strategic Alliance Partnership Program for raising awareness of ... OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to share the ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted ... 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event ... petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders ...
(Date:7/1/2015)... ... 2015 , ... “Well-meaning social policy often has unintended and ... School of International and Public Affairs. , The researchers examined longitudinal ... Survey on Drug Use and Health, which is a nationally representative survey of ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2
... tricked body, slowed down metabolism in rats , , MONDAY, ... popular artificial sweetener has the unexpected and unwelcome effect ... that saccharin altered the ability of rats to control ... trade group scoffed at the findings, saying they don,t ...
... Progress in Women,s Cancer, Theme, Spotlights Four ... Cancers, CHICAGO, Feb. 11 The Society ... Meeting on Women,s Cancer March,9-12 at the Tampa ... will feature more than 350 scientific presentations,lectures, workshops, ...
... ... ... ... Tuesday, February 12, 2008, The,James E. Marshall OCD Foundation, which benefits genetic research and,awareness for Obsessive-Compulsive Disorder, will ...
... identified a key protein target that may be a crucial ... new therapies to treat pneumonia, the leading killer of children ... of the Division of Pediatric Pulmonary Medicine, Allergy and Immunology ... a protein known as interleukin 22 (IL-22) in the immune ...
... German . , Anyone trying to build sandcastles ... and imagination, but not an instruction manual. The water ... of the sand. This observation, which is borne out ... with water content of just 3%, the fluid inside ...
... Directions, Inc. (MDI),an independent digital medical education and ... program dealing with the,management of chronic pain has ... lectures by national experts., The study, which ... and Stroke (NINDS), was reported February 5, 2008 ...
Cached Medicine News:Health News:Sugar Substitutes May Contribute to Weight Gain 2Health News:Sugar Substitutes May Contribute to Weight Gain 3Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 2Health News:Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer 3Health News:Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications 2Health News:Children's Hospital scientists identify possible target for prevention and treatment of pneumonia 2Health News:Why anyone can make a sandcastle 2Health News:Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts 2
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
... OCTEIA 25-Hydroxy Vitamin D kit is an ... and other hydroxylated metabolites in serum or ... with biotin labelled 25-OH D. The diluted ... are coated with a highly specific sheep ...
EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
Medicine Products: